ADMA icon

ADMA Biologics
ADMA

Overview Fund Activity

27 hedge funds and large institutions have $55.1M invested in ADMA Biologics in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 1 closing their positions.

Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
13
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$7.58M
2
BC
2
Broadfin Capital
New York
$6.62M
3
IHM
3
Iguana Healthcare Management
New York
$744K
4
SM
4
Sabby Management
Florida
$595K
5
UOC
5
UBS O'Connor
Illinois
$446K

Top Sellers

1
TRCT
1
Tower Research Capital (TRC)
New York
$9K
2
UBS Group
2
UBS Group
Switzerland
$1K
3
WMSA
3
Weiss Multi-Strategy Advisers
New York
$846K
4
Morgan Stanley
4
Morgan Stanley
New York
$55K
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$1K 160 -3,033 -95%
Citigroup
27
Citigroup
New York
– – -5 Closed
Bank of America
28
Bank of America
North Carolina
$0 30 +22 +275%
1
2